Total Positions
3
Quarter
2025 Q4
Top Holding
DNLI (87.0%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-3 of 3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DNLI
DENALI THERAPEU...
|
Healthcare | 87.02% | 85.26% |
#1
Prev: #1
|
10.0 | -600,000 | -17.6% |
P
S
|
2,810,732 | $46,405,185 | 2017 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SANA
SANA BIOTECHNOL...
|
Healthcare | 9.32% | 11.13% |
#2
Prev: #2
|
3.8 | -600,000 | -33.0% |
P
S
|
1,220,937 | $4,969,214 | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EGHT
8X8 INC NEW
|
Technology | 3.66% | 3.62% |
#3
Prev: #3
|
1.5 | no change | no change |
P
S
|
990,580 | $1,951,975 | 2016 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-3 of 3 holdings